Benitec Biopharma Inc.
BNTC Nasdaq
SEC CIK 1808898
Follow Benitec Biopharma
Weekly email: filings, results
Net income
−$12.9M
EPS, diluted
-
Operating cash flow
−$4.9M
Operating income
−$14.4M
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | - | −$45.7M |
| FY25 | - | −$37.9M |
| FY24 | $0 | −$21.8M |
| FY23 | $75K | −$19.6M |
| FY22 | $73K | −$18.2M |
| FY21 | $59K | −$13.9M |
| FY20 | $102K | −$8.3M |
| FY19 | $12.2M | $2.6M |
| FY18 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY26 | - | - |
| FY25 | - | - |
| FY24 | - | - |
| FY23 | −25441.3% | −26082.7% |
| FY22 | −24457.5% | −24942.5% |
| FY21 | −23044.1% | −23528.8% |
| FY20 | −8118.6% | −8111.8% |
| FY19 | 21.2% | 21.4% |
| FY18 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −$16.6M |
| FY25 | −$23.6M |
| FY24 | −$19.6M |
| FY23 | −$18M |
| FY22 | −$15.9M |
| FY21 | −$13.1M |
| FY20 | −$7.6M |
| FY19 | $4.4M |
| FY18 | - |
- Benitec Biopharma
- Healthcare median
Show the numbers
| Year | Benitec Biopharma | Healthcare median |
|---|---|---|
| FY26 | - | −11.1% |
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | −26082.7% | −58% |
| FY22 | −24942.5% | −80.4% |
| FY21 | −23528.8% | −71.8% |
| FY20 | −8111.8% | −62.2% |
| FY19 | 21.4% | −46.2% |
| FY18 | - | −49.6% |